Medical AI startup Aesop Technology raises $3 million to expand further in the US

Taiwanese medical AI startup Aesop Technology has raised $2.9 million in a funding round led by Taiwan Capital ahead of its Series A funding event. The round also attracted the participation of Colopl Next, 500 Startups and BE Capital.

A subsidiary of Taipei Medical University, the company was founded in the US in 2020 and currently has its headquarters in San Francisco. It offers two AI-powered solutions: RxPrime, a medication decision support tool, and a clinical documentation improvement tool for detecting incorrect diagnoses known as inaccuracies. DxPrimewas released in June this year.


Aesop said it will use its new capital to strengthen its technology team and further expand its presence in the US market.


The fundraising comes after it rolled out both of its solutions on the Epic App Orchard and Olive Library marketplaces over the past few months.

Last year, it published a paper with Harvard University, which demonstrated the international transferability of an AI model for drug error detection in an EHR system in the US.

Source link


Kig News: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button